[Indoleamine 2,3-dioxygenase activity during chemotherapy or hormone therapy in patients with breast cancer].
We evaluated the significance of indoleamine 2,3-dioxygenase (IDO) in breast cancer patients during chemotherapy or hormone therapy. IDO activity can be measured by tryptophan (Trp)/kynurenine (Kyn) ratio. Trp and Kyn were measured by high performance liquid chromatography (HPLC). The correlations about Trp/Kyn ratio between chemotherapy group and hormone therapy group in pre-chemotherapies or post-chemotherapies were studied. The Trp/Kyn ratio of chemotherapy group in post-FEC chemotherapy phase and in post-wPTX chemotherapy phase was higher than in pre-chemotherapy phase. And the Trp/Kyn ratio of chemotherapy group is significantly higher than hormone therapy in post-FEC chemotherapy phase and in post-wPTX chemotherapy phase. There were no significant changes for the Trp/Kyn ratio of hormone therapy group in each phase. These results suggest that the hormone therapy may be less invasive for breast cancer patients than the chemotherapy.